Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Crohn's Disease Clinical Trials

28 recruiting trials for Crohn's Disease. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
28
Total Trials
28
Recruiting Now
8
Phase 3 Trials
10
Sponsors

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT04806620

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

The unhide® Project is a non-interventional, longitudinal research study designed to establish a secure data repository of demographic, health, and lifestyle information from...

Sponsor: Brain Inflammation CollaborativeEnrolling: 100001 location
RECRUITINGPhase 1 / Phase 2NCT00692939

Autologous Stem Cell Transplantation for Crohn's Disease

The objective of this study is to evaluate the safety and effectiveness of administering high-dose chemotherapy followed by infusion of autologous CD34-selected peripheral blood...

Sponsor: Paul SzabolcsEnrolling: 202 locations
RECRUITINGPhase 2NCT06226883

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

This is a Phase 2, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of 3 active dose regimens of MORF-057 in adult study...

Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)Enrolling: 38520 locations
RECRUITINGNCT06581042

Study to Assess Treatment Patterns and Outcomes With Upadacitinib in Adult Participants With Inflammatory Bowel Disease...

Crohn's disease (CD) is an incurable chronic inflammatory disorder of the gastrointestinal tract. Ulcerative colitis (UC) is an idiopathic, chronic, inflammatory disease affecting...

Sponsor: AbbVieEnrolling: 2807 locations
RECRUITINGNCT06533228

Helmsley 3.0: Abbreviated MRE

The purpose of our study is to compare an abbreviated magnetic resonance imaging (MRI) of the bowel or magnetic resonance enterography (MRE) protocol to a conventional, standard...

Sponsor: Children's Hospital Medical Center, CincinnatiEnrolling: 3002 locations
RECRUITINGNCT07421258

A Retrospective Study to Evaluate Treat-to-Target and Disease Modification in Adult Participants With Crohn's Disease...

Inflammatory Bowel Disease (IBD), encompassing Crohn's Disease (CD) and Ulcerative Colitis (UC), is a chronic, relapsing, and often disabling condition characterized by...

Sponsor: AbbVieEnrolling: 20004 locations
RECRUITINGNCT07504510

Exclusive Enteral Nutrition Therapy for Active and Complicated Crohn's Disease

The goal of this observational study is to evaluate the effectiveness and safety of exclusive enteral nutrition (EEN) in adults with active Crohn's disease (CD), particularly in...

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen UniversityEnrolling: 3001 location
RECRUITINGNCT06882993

Feasibility of a Minimally Invasive Diagnostic Algorithm in Suspected Crohn's Disease

The goal of this clinical trial is to learn whether a camera pill examination of the whole bowel can be used to diagnose Crohn's disease instead of colonoscopy and a small bowel...

Sponsor: Esbjerg Hospital - University Hospital of Southern DenmarkEnrolling: 1655 locations
RECRUITINGPhase 3NCT06227910

A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease

The main aim of this study is to learn whether vedolizumab and upadacitinib given together (also called dual targeted therapy or DTT) reduces bowel inflammation and ulcers in the...

Sponsor: TakedaEnrolling: 39620 locations
RECRUITINGNCT06647615

A Pilot Study to Assess the Safety, Tolerability, and Efficacy of Virtual Reality for the Treatment of Abdominal Pain...

The purpose of this research is to see if patients with Crohn's disease (CD) and abdominal pain resulting in health-related quality of life deficits despite lack of evidence of...

Sponsor: Mayo ClinicEnrolling: 151 location
RECRUITINGPhase 3NCT05509777

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

Study participants will be screened during the platform study and randomly assigned to receive mirikizumab or another intervention. The purpose of the mirikizumab study is to...

Sponsor: Eli Lilly and CompanyEnrolling: 9020 locations
RECRUITINGPhase 3NCT04777656

Use of Crohn's Disease Exclusion Diet on Top of Standard Therapy Versus Standard Therapy Alone in Unstable Pediatric...

This research is a multicenter French randomized and single blinded phase III clinical trial evaluating two treatment strategies among Crohn's disease (CD) patients. The main...

Sponsor: Assistance Publique - Hôpitaux de ParisEnrolling: 1204 locations
RECRUITINGPhase 3NCT06274554

Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease

The goal of this clinical trial is to learn about the effects of fluconazole in patients who plan to start or are currently undergoing standard of care treatment and plan to...

Sponsor: Weill Medical College of Cornell UniversityEnrolling: 1201 location
RECRUITINGNCT07102368

A Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in Germany

The purpose of this study is to characterize participants with Crohn's Disease (CD) and Ulcerative Colitis (UC) treated with Guselkumab in a real-world setting, and to assess the...

Sponsor: Janssen-Cilag G.m.b.HEnrolling: 4001 location
RECRUITINGNCT06523647

Clinical Efficacy of Ustekinumab in Crohn's Disease

Clinical Efficacy of Ustekinumab in Crohn's Disease: an Observational Study With Retrospective and Prospective Components.

Sponsor: Kazakhstan Scientific Society for Study of intestine diseasesEnrolling: 1504 locations
RECRUITINGPhase 3NCT05442567

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

The study is an extension of two parent studies (MLN0002-3024 \[NCT04779307\] and MLN0002-3025 \[NCT04779320\]). Participants must have participated in one of the previous...

Sponsor: TakedaEnrolling: 24020 locations
RECRUITINGPhase 3NCT06430801

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's...

The purpose of this protocol is to evaluate the efficacy and safety of tulisokibart in participants with moderately to severely active Crohn's disease. Study 1's primary...

Sponsor: Merck Sharp & Dohme LLCEnrolling: 120020 locations
RECRUITINGPhase 4NCT06180382

Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn's Disease Patients With Loss of...

A substantial fraction of IBD patients with an initial response to infliximab or adalimumab later experience re-emerging active disease despite ongoing anti-Tumour Necrosis Factor...

Sponsor: Centre Hospitalier Universitaire de Saint EtienneEnrolling: 22012 locations
RECRUITINGNCT06211400

Vibration Exercise for Crohn's to Observe Response

Background: Crohn's disease (CD) is a long-term inflammatory condition of the digestive system. People with CD often have unpredictable and debilitating symptoms, including...

Sponsor: University of HertfordshireEnrolling: 1681 location
RECRUITINGNCT05113095

A Survey of Darvadstrocel in People With Crohn's Disease

This study is a survey in Japan of Darvadstrocel injection used to treat Crohn's disease people with complicated anal fistula. The study sponsor will not be involved in how the...

Sponsor: TakedaEnrolling: 2751 location
RECRUITINGPhase 2NCT06681324

Study Evaluating AZD7798 for Treatment in Crohn's Disease Patients With an Ileostomy

The purpose of this study is to evaluate safety, tolerability, and effect on mucosal repair of AZD7798 compared with placebo in participants with active ileal Crohn's disease and...

Sponsor: AstraZenecaEnrolling: 3020 locations
RECRUITINGPhase 3NCT06408935

Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients

The purpose of this study is to evaluate the efficacy of guselkumab in healing of all layers of the digestive tract (transmural healing) with the help of a score called Magnetic...

Sponsor: Janssen-Cilag Ltd.Enrolling: 11220 locations
RECRUITINGNCT03256240

Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis

This study proposes a randomized prospective study comparing the Kono-S anastomosis to the standard side-to-side anastomosis.This will be a multi-center randomized prospective...

Sponsor: Weill Medical College of Cornell UniversityEnrolling: 60015 locations
RECRUITINGPhase 3NCT06925594

Phase 3 Study of Human TH-SC01 Cell Injection for Treating Perianal Fistulas in Patients With Crohn's Disease

The purpose of this study is to evaluate the efficacy of human TH-SC01 cell injection for the treatment of perianal fistulas in Crohn's Disease over 24 weeks.

Sponsor: Jiangsu Topcel-KH Pharmaceutical Co., Ltd.Enrolling: 2281 location
RECRUITINGPhase 2NCT07113522

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

This is a Phase 2, multicenter, platform study in adult participants with IBD (moderately to severely active Crohn's Disease or Ulcerative Colitis). The primary goal of this study...

Sponsor: Mirador Therapeutics, Inc.Enrolling: 14020 locations
RECRUITINGNCT06548399

Longitudinal Study on Bacterial Production of LPC and LPA in Patients With Inflammatory Bowel Disease

The purpose of this study is to investigate whether the gut bacteria in IBD patients cause ongoing abdominal pain, even when the disease is calm. Many inflammatory bowel disease...

Sponsor: McMaster UniversityEnrolling: 151 location
RECRUITINGNCT07242248

A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's...

The purpose of this study is to evaluate the clinical effectiveness (how well the treatment works) of Guselkumab, by lines of treatment and subpopulations, and what are the...

Sponsor: Janssen-Cilag Ltd.Enrolling: 2201 location
RECRUITINGPhase 2NCT06764615

A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)

Crohn's Disease and Ulcerative Colitis are two types of inflammatory bowel disease (IBD), which is a serious, long-term condition in the gut (intestine) that can cause pain and...

Sponsor: TakedaEnrolling: 18316 locations

Frequently Asked Questions

There are currently 28 clinical trials for Crohn's Disease, with 28 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Crohn's Disease, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 8 Phase 3 trials for Crohn's Disease, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice — always talk to your doctor about clinical trial participation.